IMMUNOMEDICS

Summary

Immunomedics is a pharmaceutical company focusing on the development of antibody-drug conjugates for the treatment of cancer.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 16.78 B

Avg. Deal Size£ 8.39 B

Market Context

Senior Management